baber/WOPTO huggingface dataset:
Patent NZ-233196-A (NZ)
Title: Process for preparing glutaric acid derivatives and 2-alkoxycarbonylalkyl cyclohexanone derivatives
Inventor: CHALLENGER STEPHEN
IPC: C07C67/313
Filed: 1990-04-04
Abstract: The invention provides a process for preparing a compound of the formula:- <CHEM>  or a base salt thereof,  wherein R<2> is hydrogen or C1-C6 alkyl optionally substituted by up to 3 substituents each independently selected from C1-C6 alkoxy and C1-C6 alkoxy(C1-C6 alkoxy)-; and R<3> is C1-C6 alkyl or benzyl, said benzyl group being optionally ring-substituted by up to 2 nitro or C1-C4 alkoxy substituents,  comprising reaction of a compound of the formula:- <CHEM>  wherein  R<1> is C1-C4 alkyl, phenyl, benzyl or C1-C4 alkoxy; and R<2> and R<3> are as previously defined for a compound of the formula (I), with hydrogen peroxide or a source of peroxide ions: said process being optionally followed by conversion of the compound of the formula (I) to a base salt thereof.
Patent NZ-233601-A (NZ)
Title: N-terminal acylated peptides having an initial sequence met (or nle) -leu-phe and having a detectable label bound through dtpa or edta to a c-terminal lys or pu residue
Inventor: FISCHMAN ALAN JAY
IPC: A61K38/08
Filed: 1990-05-08
Abstract: Chemotactic peptides are disclosed which comprise a peptide having the general formula:  N - X - Y - Leu - Phe - Z - W  wherein:  X is a bulky group;  Y is Met or Nle;  Z is a bond or a spacer sequence; and W is a detectable label or a substituent for attaching a label or for attachment to a carrier. Compositions containing these chemotactic peptides are also disclosed. These compositions are useful for instance in the form of pharmaceutical compositions for treating a localized site of infection or inflammation in an individual.
Patent NZ-237722-A (NZ)
Title: Certain 1,4-dihydro-pyridine carboxylic acid esters and pharmaceutical compositions thereof
Inventor: BEHNER OTTO
IPC: C07D211/90
Filed: 1991-04-08
Abstract: The present invention relates to the use of N-alkylated 1,4-dihydropyridinedicarboxylic acid esters, some of which are known, of the general formula I 
<IMAGE>
 as a haemorheological drug, new active substances and a process for their preparation, in particular their use as drugs in acute and chronic ischaemic diseases which are associated with microcirculation disorders. This action can occur both in the peripheral and in the cerebral vascular systems.
Patent NZ-246503-A (NZ)
Title: Catheter with high frequency voltage terminals on distal end surface
Inventor: EGGERS PHILIP E
IPC: A61B17/22
Filed: 1992-12-28
Abstract: An apparatus for localized heating has a plurality of independent electrode terminals. The current flow to the electrode terminals can be independently controlled so that the presence of a low-resistance current flow path from one of the electrode terminals does not draw undue power and present power being delivered to an electrode terminal associated with a higher resistance current flow path. Current control may be active or passive. <IMAGE>
Patent NZ-254704-A (NZ)
Title: Anti-cancer compositions containing whey protein concentrate containing at least 9% serum albumin and their use
Inventor: GOLD PHIL
IPC: A61K33/24
Filed: 1993-08-05
Abstract: This invention relates to a method of treatment of patients having lesions resulting from cancer cells and to an application as an anti-cancer composition of undenatured whey protein concentrate.
Patent NZ-258662-A (NZ)
Title: Treating a metallic surgical implant with an aqueous solution containing sodium fluoride
Inventor: ELLINGSEN JAN EIRIK
IPC: A61L27/00
Filed: 1993-12-01
Abstract: PCT No. PCT/SE93/01032 Sec. 371 Date May 30, 1995 Sec. 102(e) Date May 30, 1995 PCT Filed Dec. 1, 1993 PCT Pub. No. WO94/13334 PCT Pub. Date Jun. 23, 1994Metallic surgical implant materials having improved strength of connection with bone are produced when the implants are treated prior to implantation with an aqueous solution of sodium fluoride.
Patent NZ-265692-A (NZ)
Title: Indole- and benzofuran- containing hydroxyamines and analogs; pharmaceutical compositions
Inventor: DOW ROBERT L
IPC: A61K31/505
Filed: 1994-05-20
Abstract: PCT No. PCT/IB94/00117 Sec. 371 Date Dec. 14, 1995 Sec. 102(e) Date Dec. 14, 1995 PCT Filed May 20, 1994 PCT Pub. No. WO94/29290 PCT Pub. Date Dec. 22, 1994The present invention relates to compounds of the formula    <IMAGE>  I  having utility as hypoglycemic and antiobesity agents, methods for their use and pharmaceutical compositions containing them. The compounds of the present invention also possess utility for increasing lean meat deposition and/or improving lean meat to fat ratio in edible animals, i.e. ungulate animals and poultry.
Patent NZ-277057-A (NZ)
Title: Antibody specific for carcinoembryonic antigen
Inventor: CHESTER KERRY ANNE
IPC: A61K47/48
Filed: 1994-12-05
Abstract: PCT No. PCT/GB94/02658 Sec. 371 Date Jul. 2, 1996 Sec. 102(e) Date Jul. 2, 1996 PCT Filed Dec. 5, 1994 PCT Pub. No. WO95/15341 PCT Pub. Date Jun. 8, 1995The invention provides an antibody specific for carcinoembryonic antigen (CEA) which has a dissociation constant (Kd; of less than 5.0 nM for said antigen. The antibody is generally a single chain Fv (scFv) antibody. The antibody was initially obtained by screening a bacteriophage library for phage expressing high affinity CEA antibody. The antibody is useful for diagnosis and therapeutic treatment of colorectal tumors.
Patent NZ-312995-A (NZ)
Title: Washable coated abrasives
Inventor: GAETA ANTHONY C
IPC: B24D11/00
Filed: 1996-07-16
Abstract: A washable coated abrasive material comprising a substrate and maker, size and optionally supersize coats and a functionalized polysiloxane modifying the binder of the outermost layer.
Patent NZ-313691-A (NZ)
Title: Flanged capsule containing inner and outer housing and bursting upon removal of container closure
Inventor: FRUTIN BERNARD DEREK
IPC: B65D83/14
Filed: 1996-07-29
Abstract: PCT No. PCT/GB96/01803 Sec. 371 Date Jan. 28, 1998 Sec. 102(e) Date Jan. 28, 1998 PCT Filed Jul. 29, 1996 PCT Pub. No. WO97/05039 PCT Pub. Date Feb. 13, 1997A first container (60) contains a first liquid. The first container includes an opening which is closed by a releasable closure (61) and a second container (20) located in the first container (60) adjacent the opening of the first container (60). The second container (20) contains a fluid (15,16) and the second container (20) is adapted to release the fluid (15,16) into the first container (60) and into contact with the first liquid on release of the closure (61) from the first container (60).
Patent NZ-314091-A (NZ)
Title: Streptococcus equi strain tw 928, live vaccine for combating streptococcus infection in horses
Inventor: HARTFORD ORLA MARY
IPC: A61P31/04
Filed: 1997-01-21
Abstract: The present invention relates to a live attenuated strain of the bacterium Streptococcus equi, a pathogen causing strangles in horses. The invention also relates to a vaccine against strangles, methods for the preparation of such a vaccine and to the use of the strain for the preparation of such a vaccine.
Patent NZ-333182-A (NZ)
Title: Enteric coating comprising alginic acid and a water soluble binding agent for an oral preparation
Inventor: MARCUSSEN JORN
IPC: A23L29/00
Filed: 1997-06-06
Abstract: A composition for formulation of an enteric coating on an oral preparation is claimed comprising a liquid mixture of a major amount of alginic acid particles dispersed in an aqueous solution of a minor amount of water soluble binding agent which is approved for use for coating foodstuffs and/or food supplements. The binding agent is locust bean gum, gelatine, vegetable hydrocolloids or animal proteins.
Patent NZ-336254-A (NZ)
Title: 5,10-dihydrodipyrido[2,3-b:2,3-e] pyrazin compounds and their use in cancer treatment
Inventor: CAUBERE PAUL
IPC: C07D471/14
Filed: 1999-06-11
Abstract: The specification describes 5, 10-dihydropyrido[2,3-b:2,3-e]pyrazin and 5,10- dihydropyrido[2,3-b:3,2-e]pyrazin compounds of the formula 1 where; X is N, C or CH Y is C or CH R1 is C1-6 alkyl which can be optionally substituted; R2 and R3 represent a Z group or one of the R2 and R3 represent a W group and the other a Z group where Z is H, hal, alkyl, amino, nitro, C1-6alkylthio, formyl, hydroxycarbonyl, C1-6alkoxycarbonyl, aminocarbonyl and monoalkylaminocarbonyl and W is C5-24alkylene chain where any carbon atom can be replaced by O, imine.  The alkylene chain is further substituted by a three-ringed heterocyclic in the terminal position. These compounds are used for treating cancer.
Patent NZ-501597-A (NZ)
Title: Shellfish processing method comprising blow drying, applying oil, draining, sealing in a vacuum bag, cooking and cooling
Inventor: WILSON NEIL DAVID
IPC: A22C29/04
Filed: 1999-12-06
Abstract: This method of treating shellfish comprises: a)   blow drying the shellfish by means of heated, unheated or dehydrated air; b)   applying an edible oil such as a vegetable, animal, synthetic or mineral oil,        to the shellfish; c)   draining the oiled product for up to 24 hours; d)   vacuum sealing the oiled product in a vacuum bag; e)   cooking the vacuum bagged product in an immersion type cooker or the like for up to 5 minutes at an immersion medium temperature of up to 99°C; f)   allowing the vacuum bagged product to cool to about 60 or 70°C; g)   cooking the vacuum bagged product at about 60 to 70°C for up to 15 minutes; h)  cooling the cooked product in an ice slurry or similar for up to 30 minutes and       blast freezing the bagged product to substantially -18°C. Addition to 501597
Patent NZ-503698-A (NZ)
Title: 5-Hydroxytryptamine (5-HT) receptor antagonists for use in the treatment of inflammatory bowel syndrome (IBS)
Inventor: MANGEL ALLEN WAYNE
IPC: A61K31/55
Filed: 1998-10-05
Abstract: Use of a 5-HT3 receptor antagonist or a pharmaceutically acceptable derivate thereof selected from granisetron, azasetron, tropisetron, ramosetron, ondansetron, leristeron, (R) zacopride, cilansetron, itasetron, indisetron or dolasetron in the manufacture of a medicament for the treatment of nonconstipated female irritable bowel syndrome.
Patent NZ-504424-A (NZ)
Title: Insect cells or fractions as adjuvant for antigens
Inventor: SMITH GALE EUGENE
IPC: A61K39/39
Filed: 1998-11-04
Abstract: Disclosed is an adjuvant for immunogenic, immunological, antigenic or vaccine compositions. The adjuvant is composed of insect cells or fractions thereof. Also disclosed are methods for preparing and using the adjuvant and compositions containing the adjuvant. Advantageously, a recombinant baculovirus containing DNA encoding and expressing an epitope of interest or antigen can be infected into insect cells such as insect cells derived from a Lepidopteran species such as S. frugiperda for expression, and the infected insect cells or a fraction thereof can be used with the expressed epitope of interest or antigen as an inventive antigen or in an inventive immunological, antigen or vaccine composition.
Patent NZ-505952-A (NZ)
Title: Compositions comprising viruses and methods for concentrating virus preparations
Inventor: FREI ANDREAS
IPC: C12N7/00
Filed: 1999-02-12
Abstract: A composition is disclosed comprising virus in a formulation comprising glycerol, buffered to maintain a pH in a range from about 7 to about 8.5 at a temperature in the range from about 2 DEG C to 27 DEG C. The composition may additionally include a disaccharide, a divalent metal salt and water. Methods for concentrating and purifying virus preparations are also disclosed.
Patent NZ-512656-A (NZ)
Title: Desaturases and methods of using them for synthesis of polyunsaturated fatty acids
Inventor: BROWSE JOHN A
IPC: C12N1/19
Filed: 1999-12-06
Abstract: The amino acid and nucleic acid sequences of  a  "5  - desaturase  enzyme  from Caenorhabditis elegans  and  a  "8- desaturase  enzyme from Euglena gracilis are disclosed.  The nucleic  acid  sequences can be used to  design  recombinant DNA  constructs and vectors. These vectors can then be  used to  transform  various  organisms,  including  for  example, plants  and  yeast.  The  transformed  organisms  will  then produce   polyunsaturated  fatty  acids.  The   amino   acid sequences   are   useful   for  generating   enzyme-specific antibodies that are useful for identifying the desaturases.
Patent NZ-517977-A (NZ)
Title: Sensor with memory containing digital signature for authentication of sensor and sensor data
Inventor: BERSON THOMAS A
IPC: G06F1/00
Filed: 2000-09-28
Abstract: A sensor has codes useful for a monitor which can be authenticated as accurate. The sensor produces a signal corresponding to a measured physiological characteristic and provides codes which can be assured of being accurate and authentic when used by a monitor. A memory associated with the sensor stores both data relating to the sensor and a digital signature. The digital signature authenticates the quality of the code by ensuring it was generated by an entity having predetermined quality controls, and ensures the code is accurate.
Patent NZ-519317-A (NZ)
Title: Pre-stressed modular retaining wall system and method
Inventor: LEWIS CYRRUS G
IPC: E02D17/20
Filed: 2000-12-15
Abstract: A system and a method for constructing pre-stressed modular retaining walls.  The system comprises a plurality of header stacks constructed from a variety of header units.  The first header unit being disposed in a recess that is compliant with the header units shape.  The header stacks are coupled by structural members.  Active reinforcement elements are used to induce a pre-stressing force into the header stacks to support or retain the applied load.
Patent NZ-522758-A (NZ)
Title: Luminescent marking of piece to be cut or welded
Inventor: O'CONNELL DENNIS JAMES
IPC: B23K31/00
Filed: 2000-06-30
Abstract: Products for aiding welding or high temperature cutting operations comprise a work piece marker and a welding or cutting aid system. The marker includes a luminescent material which is excited by UV radiation generated during arc welding to emit light in the visible spectrum, e.g. orange light. The aid system includes a light filter matched to the visible emission wavelength of the marker interposed in the light path, adjacent the dark filter of a welder's mask. The marker is used to mark a weld or cutting path trace visible to the welder during the operation. A method of aiding a welding or cutting operation using the marker and matched light filter is also provided.
Patent NZ-524909-A (NZ)
Title: Antimicrobial compositions formulated for use in cold temperature conditions and methods of use thereof
Inventor: RICHTER FRANCIS LAWRENCE
IPC: A61K31/20
Filed: 2001-10-01
Abstract: A method for controlling bovine mastitis comprising: Applying an antimicrobial composition to a teat of an animal wherein the antimicrobial composition comprises in the range 0.01 to 5 wt% of a C6-C12 fatty acid and a carrier medium including a freezing point depressant component, wherein the freezing point depressant component comprises greater than 60 wt% of the composition.
Patent NZ-525452-A (NZ)
Title: Novel structures comprising phytosterol and/or phytostanol and ascorbic acid and use thereof as weight regulating agents
Inventor: KUTNEY JAMES P
IPC: A23L33/20
Filed: 2001-10-25
Abstract: Use of one or more of the structures having the following formulae (I), (II) and (III) and all salts of these structures in the manufacture of a composition for use in a method of weight control in an animal is disclosed, wherein R is a sterol or stanol moiety, R2 is an ascorbic acid moiety and R3 is hydrogen or any metal, alkali earth metal or alkali metal; and wherein the sterol may be selected from the group consisting of sitosterol, campesterol, stigmasterol, brassicasterol, desmosterol, chalinosterol, poriferasterol, clionasterol, ergosterol, coprosterol, codisterol, isofucosterol, fucosterol, clerosterol, nervisterol, lathosterol, stellasterol, spinasterol, chondrillasterol, peposterol, avenasterol, isoavenasterol, fecosterol, pollinastasterol and cholesterol; and wherein the stanol is selected from the group consisting of all saturated or hydrogenated sterols such as sitostanol.
Patent NZ-526278-A (NZ)
Title: The use of sulfur-containing fuels for direct oxidation fuel cells
Inventor: GORTE J RAYMOND
IPC: H01M8/12
Filed: 2001-11-09
Abstract: A solid oxide fuel cell comprising: (a) a solid electrolyte comprised of an electronic insulator that allows transfer of anions, a ceramic-metal composite anode containing at least ceria and/or copper, and a cathode, at least the solid electrolyte and anode being prepared by forming at least two layers to form a porous anode layer and a dense solid electrolyte layer, and then impregnating the porous anode layer with at least ceria and/or copper, (b) a fuel comprising a sulfur-containing hydrocarbon having a sulfur content of from 1 ppm to 500 ppm, and (c) an oxygen source. The above fuel cell is used in a process of producing electrical energy, wherein the cathode is contacted with an oxygen source and the anode is contacted with a sulfur containing fuel.
Patent NZ-530151-A (NZ)
Title: Apparatus and methods for facilitating wound healing
Inventor: ANDINO RAFAEL
IPC: A61N1/20
Filed: 2002-05-31
Abstract: Disclosed is an electrode system for facilitating the healing of a wound, comprising a support structure, a first electrode attached to the support structure, a first adhesive material attached to the first electrode, wherein the first adhesive material is an electrically conductive material, wherein the first adhesive material attaches the first electrode to the wound when the electrode system is applied to the wound, and wherein the first adhesive material is attached to the first electrode such that when the electrode system is applied to the wound, the first electrode is not directly in contact with the wound, and a second electrode attached to the support structure, wherein the second electrode surrounds the first electrode on the support structure and wherein when the electrode system is applied to the wound and when a voltage potential is applied across the first and the second electrodes, a current is caused to flow between the first and the second electrodes, thereby passing through the wound.
Patent NZ-533798-A (NZ)
Title: Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an anti-inflammatory agent and their use for the prevention or treatment of neurodegenerative disease
Inventor: SMITH TERENCE
IPC: C07D401/12
Filed: 2002-12-06
Abstract: The invention provides a composition comprising I) a compound represented by the formula (I), a salt thereof or a hydrate thereof, wherein: Q indicates NH, O or S; R1, R2, R3, R4 and R5 are the same as or different from each other and each indicates hydrogen atom, a halogen atom, a C1-6 alkyl group or a group represented by the formula -X-A; X indicates a single bond, an optionally substituted C1-6 alkylene group, an optionally substituted C2-6 alkenylene group, an optionally substituted C2-6 alkynylene group, -O-, -S-, -CO-, -SO-, -SO2-, -N(R6)-, -N(R7)-CO-, -CO-N(R8)-, -N(R9)-CH2-, -CH2-N(R10)-, -CH2-CO-, -CO-CH2-, - N(R11)-S(O)m-, -S(O)n-N(R12)-, -CH2-S(O)p-, -S(O)q-CH2-, -CH2-O-, -O-CH2-, -N(R13)-CO-N(R14)- or -N(R15)-CS-N(R16)-; wherein R6, R7, R8, R9, R10, R11, R12, R13, R14, R15 and R16 indicate hydrogen atom, a C1-6 alkyl group or a C1-6 alkoxy group, and m, n, p and q indicates an integer of 0,1 or 2 independently; A indicates a C3-8 cycloalkyl group, a C3-8 cycloalkenyl group, a 5 to 14 membered non-aromatic heterocyclic group, a C6-14 aromatic hydrocarbocyclic group, or a 5 to 14 membered aromatic heterocyclic group which may be substituted respectively, provided that 3 groups among R1, R2, R3, R4 and R5 each indicates -X-A; wherein each -X-A is the same or different and the remaining 2 groups are selected from hydrogen atom, a halogen atom or a C1-6 alkyl group); and II) an immunoregulatory or anti-inflammatory agent; for the prevention or treatment of neurodegenerative disease.
Patent NZ-534690-A (NZ)
Title: Use of ophthalmic composition comprising ascomycin for treating blepharitis
Inventor: BABIOLE SAUNIER MAGGY
IPC: A61P31/04
Filed: 2003-03-03
Abstract: Disclosed is a use of an ophthalmic composition comprising an ascomycin (such as 33-epi-chloro-33-desoxy ascomycin) and a carrier comprising a medium chain triglyceride in the manufacture of a medicament for the treatment of blepharitis (such as seborrhoeic blepharitis or allergic blepharitis, or staphylococcal blepharitis).
Patent NZ-536555-A (NZ)
Title: Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
Inventor: FELDMAN DAVID LOUIS
IPC: A61P21/00
Filed: 2003-05-16
Abstract: A pharmaceutical composition comprising (i) a renin inhibitor (ii) a calcium channel blocker; and (iii) a diuretic selected from the group consisting of bumetanide, ethacrynic acid, furosemide, torsemide, amiloride, spironolactone, triamterene, chlorothalidone, chlorothiazide, hydrochlorothiazide, hydroflumthiazide, methylchlothizide, metolazone, and dichlorophenamide. The pharmaceutical composition can be used to treat a condition or a disease selected from the group consisting of hypertension, heart failure such as (acute and chronic) congestive heart failure, left ventricular dysfunction and hypertrophic cardiomyopathy, diabetic cardiac myopathy, supraventricular and ventricular arrhythmias, atrial fibrillation, atrial flutter, detrimental vascular remodeling, myocardial infarction and its sequelae, atherosclerosis, angina (whether unstable or stable), renal insufficiency (diabetic and non- diabetic), heart failure, angina pectoris, diabetes, secondary aldosteronism, primary and secondary pulmonary hypertension, renal failure conditions, such as diabetic nephropathy, glomerulonephritis (including IgA nephropathy), renal fibrosis, scleroderma, glomerular sclerosis, proteinuria of renal disease, and also renal vascular hypertension, diabetic retinopathy, the management of other vascular disorders, such as migraine, peripheral vascular disease, Raynaud's disease, luminal hyperplasia, cognitive dysfunction (such as Alzheimer's), glaucoma and stroke, pulmonary and hepatic fibrosis, fibrotic diseases resulting from accumulation of excess extracellular matrix induced by TGF, and proliferative diseases of smooth muscle cells, including uterine fibroids
Patent NZ-536993-A (NZ)
Title: Connector system
Inventor: CHANDLER MARTYN WALKER
Filed: 2004-12-03
Abstract: A connector for connecting a fixture to an elongate member having a plurality of longitudinally spaced nubs thereon aligned with the axis of the member, the connector includes one or more apertures suitable for slidingly receiving at least part of a post therein so as to allow longitudinal sliding movement of the connector along the member. A locking portion is moveable between locking and released positions, wherein in the locking position the locking portion is configured to engage with at least one nub on the member to prevent movement of the connector in at least one direction along the member, and in the released position the locking portion may pass over each nub as the connector slides along the member. Mounting portions are provided for receiving and supporting the fixture, and wherein the mounting portions and locking portion are configured such that when the fixture is received on the mounting portions, the fixture engages the locking portion to prevent movement of the locking portion to the released position.